WASHINGTON, D.C. – The U.S. Food and Drug Administration (FDA) will now allow authorized, state-licensed pharmacists to prescribe Paxlovid, an oral treatment for COVID-19.
Rep. Earl L. “Buddy” Carter (R-GA), a pharmacist by trade, sees this Emergency Use Authorization expansion as the necessary link between COVID-19 patients and treatment:
“Pharmacists are the… Read more »
WASHINGTON, D.C. – In the face of a nationwide mental health crisis, the U.S. House of Representatives, with support from Rep. Earl L. “Buddy” Carter (R-GA), today passed the bipartisan Restoring Hope for Mental Health and Well-Being Act, which will improve school safety for young Americans and provide necessary aid to those suffering from severe mental illness.
“This is how we heal… Read more »
WASHINGTON, D.C. – The entire Georgia Congressional delegation, led by Rep. Earl L. “Buddy” Carter (R-GA) and Senator Raphael Warnock (D-GA), sent a letter to Health and Human Services (HHS) Secretary Xavier Becerra urging him to house the Advanced Research Projects Agency for Health (ARPA-H) headquarters in Georgia.
In the letter, which was also sent to the White House and Acting… Read more »
WASHINGTON, D.C. – In a major win for patients, the Federal Trade Commission (FTC) today unanimously approved to launch an inquiry examining pharmacy benefit managers' (PBMs) unfair and deceptive business practices.
This announcement comes after years of advocacy from Rep. Buddy Carter (R-GA), a pharmacist by trade, who recently wrote a letter to the FTC calling for an investigation… Read more »
WASHINGTON, D.C. – In a letter to Federal Trade Commission (FTC) Chair Lina M. Khan, Rep. Earl L. “Buddy” Carter (R-GA) called for an investigation into Pharmacy Benefit Manager’s (PBMs) predatory practices, which lead to higher prices on prescription medications for patients.
Rep. Carter, a pharmacist by trade, is joined by fellow pharmacist Rep. Diana Harshbarger (R-TN) in… Read more »
WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA) led a letter, signed by 15 Members of the GOP Doctors Caucus, to World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus today advocating for Taiwan’s inclusion in the organization.
The WHO’s continued exclusion of Taiwan is a kowtow to the Chinese Communist Party, who refuse to acknowledge Taiwan as the… Read more »
WASHINGTON, D.C. – Today is the first annual National Fentanyl Awareness Day. Rep Earl L. “Buddy” Carter (R-GA), a pharmacist by trade, is educating families about the dangers of this lethal drug.
“Fentanyl overdoses are at an all-time high. This drug, often disguised as a simple painkiller, is ravaging our communities,” said Carter. “As a pharmacist, I am calling on the public to… Read more »
WASHINGTON, D.C. – The Energy and Commerce Committee unveiled its bipartisan package to reauthorize the Food and Drug Administration (FDA) User Fee Agreements. The package, introduced by Health Subcommittee Republican Leader Brett Guthrie (R-KY) and Health Subcommittee Chairwoman Anna G. Eshoo (D-CA), includes four provisions led by Rep. Earl L. “Buddy” Carter (R-GA) that would… Read more »
WASHINGTON, D.C. – Since day one in Congress, Rep. Earl L. “Buddy” Carter (R-GA) has been sounding the alarm on the predatory practices of the pharmaceutical industry’s middlemen, pharmacy benefit managers (PBMs).
Following Rep. Carter’s March, 2022 call with Federal Trade Commission (FTC) Chair Lina Khan, she publicly agreed that PBMs reduce patient’s access to life-saving… Read more »
WASHINGTON, D.C. – Today, Rep. Earl L. "Buddy" Carter (R-GA) joined Reps. Ron Kind (D-WI), David B. McKinley (R-WV), and Nanette Diaz Barragán (D-CA) in introducing the bipartisan Equitable Community Access to Pharmacist Services Act. This legislation will help ensure patients can continue to access COVID-19 pandemic and pandemic-related health services from pharmacists and… Read more »
